Arvind Patel

Professor Arvind Patel is a distinguished virologist at the University of Glasgow, holding the position of Professor of Viral Vaccinology. Based at the Centre for Virus Research in the Sir Michael Stoker Building, he leads groundbreaking research on hepatitis C virus (HCV) and emerging viral pathogens including SARS-CoV-2 and Zika virus. His work spans molecular virology, vaccine development, and host-pathogen interactions, with significant contributions to understanding viral entry mechanisms and immune evasion strategies.

Professor Patel's research program focuses on several critical areas of viral pathogenesis and control. His laboratory investigates the molecular aspects of virus infection and replication, with particular emphasis on virus entry and morphogenesis mechanisms. A major component of his work examines virus-host interactions and viral pathogenesis, especially factors involved in progression to liver disease in HCV infection. His team studies host immunity in HCV-infected patient cohorts, with specific attention to B-cell and antibody responses and their links with extrahepatic disorders. Additionally, Professor Patel leads innovative vaccine development efforts using structural and antibody-based approaches, and conducts high-throughput screening of compound libraries to identify novel viral inhibitors.

Analysis of Professor Patel's recent publications reveals a strategic expansion of his research focus from traditional HCV studies to include emerging viral threats such as SARS-CoV-2 and Zika virus. His work demonstrates consistent expertise in viral entry mechanisms, immune evasion, and structural virology across multiple viral families. The research shows strong translational potential, with applications in vaccine design, antiviral development, and understanding viral evolution during pandemics. His interdisciplinary approach integrates molecular virology, structural biology, and clinical research to address pressing public health challenges.

Professor Patel maintains strong collaborative networks through the Glasgow HCV Network, a local consortium of clinicians and scientists focused on improving outcomes for HCV-infected individuals, and HCV Research UK, a national consortium establishing clinical databases and biobanks to advance HCV research. His laboratory at the Centre for Virus Research serves as a hub for virology research, bringing together expertise in viral structure, pathogenesis, and therapeutic development to tackle some of the most challenging viral diseases affecting global health.